Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

TSPO might help treat anxiety and depression.

Key genes and pathways involved in thyroid eye disease were identified, aiding potential treatment and diagnosis.

The TRPV3 channel structure changes linked to severe itch and hyperkeratosis were identified using cryo-EM.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Resident memory T cells and necroptosis may drive fibrosis in eosinophilic fasciitis and morphea.

TRPA1 is crucial for mechanical sensitivity in skin sensory neurons.

ELL is crucial for gene transcription related to skin cell growth.

Engineered cytokines show promise for improving tissue healing and safety in regenerative medicine.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

ERK activation spreads between cells in mouse skin, linked to cell division and influenced by TPA and EGF receptors.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

MPA increases cancer spread by boosting Eph A2 activity.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

mEphA1 receptor tyrosine kinase is important for skin and hair development and may play a role in certain diseases.

A defective protein in progeria causes cell death and atherosclerosis, but a treatment targeting cell stress may reduce these effects.

The research suggests that Tourette syndrome is linked to both brain signaling and immune system pathways.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

The peptide IMT-P8 can effectively deliver proteins into the skin and cells for potential skin treatments.

Transglutaminase-3 is often reduced in esophageal cancer.

Mitochondrial genes help predict breast cancer outcomes and spread.